Talk:Protectin D1
Appearance
This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Protectin D1.
|
This is the talk page for discussing improvements to the Protectin D1 article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Proposed merge of Neuroprotectin into Protectin D1
[edit]Both articles describe the same thing and have largely the same content. — CrafterNova [ TALK ] [ CONT ] 04:42, 5 November 2022 (UTC)
- Support --Iztwoz (talk) 18:01, 1 May 2023 (UTC)
Categories:
- C-Class pharmacology articles
- Low-importance pharmacology articles
- WikiProject Pharmacology articles
- C-Class medicine articles
- Low-importance medicine articles
- All WikiProject Medicine pages
- C-Class Molecular Biology articles
- Unknown-importance Molecular Biology articles
- C-Class MCB articles
- Low-importance MCB articles
- WikiProject Molecular and Cellular Biology articles
- All WikiProject Molecular Biology pages
- C-Class chemicals articles
- Low-importance chemicals articles